Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations.

Nenclares, Pablo; Rullan, Antonio; Tam, Kenric; Dunn, Lara A; St John, Maie; Harrington, Kevin J

Nenclares, Pablo; Rullan, Antonio; Tam, Kenric; Dunn, Lara A; St John, Maie; Harrington, Kevin J.

Afiliação

Nenclares P; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
Rullan A; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.
Tam K; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
Dunn LA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
St John M; Department of Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA.
Harrington KJ; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom.

Am Soc Clin Oncol Educ Book ; 42: 1-16, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35522916

Assuntos

Neoplasias de Cabeça e Pescoço; Inibidores de Checkpoint Imunológico; Neoplasias de Cabeça e Pescoço/tratamento farmacológico; Humanos; Imunoterapia; Terapia Neoadjuvante; Carcinoma de Células Escamosas de Cabeça e Pescoço/terapia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Am Soc Clin Oncol Educ Book Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google